AAOpt 2024: Alcon launches first ever one-week replacement contact lens, PRECISION7

News
Article

Broad commercial availability of the lens is expected in the beginning of January 2025.

Contact lenses demonstrated to patient Image credit: AdobeStock/Svitlana

Image credit: AdobeStock/Svitlana

Alcon has announced the launch of PRECISION7, a one-week replacement contact lens, in the US.1 The lens, which utilizes a 7-day ACTIV-FLO System that provides 16 hours of comfort and clear vision, is the only one-week replacement lens on the market, according to a news release.

“We are making history with the bold innovation of PRECISION7,” said Max Wolf, general manager and head of Vision Care and Contact Lenses at Alcon, in the release. “Now, patients can start and end every week fresh with a first of its kind contact lens featuring ACTIV-FLO technology. This is also the first time we are introducing both sphere and toric lenses to the US market simultaneously, allowing eye care professionals to address the needs of the majority of patients right away.”

Presicion7 contact lenses are the first weekly replacement lens on the market - Image courtesy of Alcon

Image courtesy of Alcon.

According to the release, more than half of new patients are being fit in reusable lenses due to cost consideration, even though almost 9 out of 10 eye care providers believe daily disposable lenses are better overall for their patients. A majority of optometrists also agree that a one-week contact lens replacement schedule may be a more intuitive option for their patients, in contrast to a 2-week replacement schedule.1

As for the workings of ACTIV-FLO, a combination of a moisturizing agent embedded in a lens matrix and a continually released proprietary replenishing agent act to moisturize the serafilcon A lens for 7 days.1

“Data show that 3 out of every 4 contact lens wearers want their eye care professionals to talk to them about new contact lens technology,” said Jason Compton, OD, FAAO. “When daily disposable lenses aren’t an option, PRECISION7 provides 16 hours of outstanding comfort and precise vision, even on day 7, at a price our patients can afford. It has an easy and intuitive replacement schedule that allows my patients to pick their preferred day of the week to replace their contact lenses.”

PRECISION7 has been launched as an addition to the Alcon WaterInnovations portfolio of contact lenses. While sphere and toric lenses are immediately available through select eye care providers in the US, broad commercial availability is expected in the beginning of January 2025. Markets outside the US will then follow.1

Reference:
  1. Alcon debuts groundbreaking PRECISION7, a one-week replacement contact lens to start and end every week fresh. Alcon. November 7, 2024. Accessed November 7, 2024.
Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.